PL413202A1 - Method for receiving helenalin and dihydrohelenalin and esters of these substances from in vitro cultures of Arnica and their application - Google Patents
Method for receiving helenalin and dihydrohelenalin and esters of these substances from in vitro cultures of Arnica and their applicationInfo
- Publication number
- PL413202A1 PL413202A1 PL413202A PL41320215A PL413202A1 PL 413202 A1 PL413202 A1 PL 413202A1 PL 413202 A PL413202 A PL 413202A PL 41320215 A PL41320215 A PL 41320215A PL 413202 A1 PL413202 A1 PL 413202A1
- Authority
- PL
- Poland
- Prior art keywords
- esters
- substances
- application
- dihydrohelenalin
- helenalin
- Prior art date
Links
- 150000002148 esters Chemical class 0.000 title abstract 2
- 238000000338 in vitro Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000126 substance Substances 0.000 title abstract 2
- ICKWITMQEROMDG-MIYBGKPYSA-N (1s,3ar,5s,5ar,8ar,9s,9as)-9-hydroxy-1,5,8a-trimethyl-3a,4,5,5a,9,9a-hexahydro-1h-azuleno[6,7-b]furan-2,8-dione Chemical compound C1[C@H](C)[C@@H]2C=CC(=O)[C@@]2(C)[C@@H](O)[C@@H]2[C@H](C)C(=O)O[C@H]12 ICKWITMQEROMDG-MIYBGKPYSA-N 0.000 title 1
- 241000086254 Arnica montana Species 0.000 title 1
- OSSDUQKWVVZIGP-UHFFFAOYSA-N Aromaticin Natural products CC1CC2OC(=O)C(=C)C2CC2(C)C(=O)C=CC12 OSSDUQKWVVZIGP-UHFFFAOYSA-N 0.000 title 1
- ZVLOPMNVFLSSAA-UHFFFAOYSA-N Heleanalin Natural products CC1CC2OC(=O)C(=C)C2C(O)C2(C)C(=O)C=CC12 ZVLOPMNVFLSSAA-UHFFFAOYSA-N 0.000 title 1
- RFBYGVGDYMSKTD-UHFFFAOYSA-N Helenalin Natural products CC1CC2OC(=O)C(=C)C2C(O)C3C(C)C(=O)C=C13 RFBYGVGDYMSKTD-UHFFFAOYSA-N 0.000 title 1
- AFTUDGRDUWDYHE-UHFFFAOYSA-N Mexicanin I Natural products CC1CC2OC(=O)C(=C)C2C(O)C3(C)C1CC=C3C AFTUDGRDUWDYHE-UHFFFAOYSA-N 0.000 title 1
- ICKWITMQEROMDG-UHFFFAOYSA-N Mexicanin-C Natural products C1C(C)C2C=CC(=O)C2(C)C(O)C2C(C)C(=O)OC12 ICKWITMQEROMDG-UHFFFAOYSA-N 0.000 title 1
- ICKWITMQEROMDG-PFSAVQFYSA-N Plenolin Natural products O=C1[C@@H](C)[C@@H]2[C@@H](O)[C@]3(C)C(=O)C=C[C@@H]3[C@H](C)C[C@@H]2O1 ICKWITMQEROMDG-PFSAVQFYSA-N 0.000 title 1
- ZVLOPMNVFLSSAA-XEPQRQSNSA-N helenalin Chemical compound C[C@@H]1C[C@H]2OC(=O)C(=C)[C@H]2[C@H](O)[C@]2(C)C(=O)C=C[C@@H]12 ZVLOPMNVFLSSAA-XEPQRQSNSA-N 0.000 title 1
- 241000415501 Anthyllis montana Species 0.000 abstract 2
- 241000086346 Arnica chamissonis Species 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000000604 anti-edema agent Substances 0.000 abstract 1
- 230000003501 anti-edematous effect Effects 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 239000000022 bacteriostatic agent Substances 0.000 abstract 1
- 230000003385 bacteriostatic effect Effects 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Przedmiotem zgłoszenia jest sposób pozyskiwania helenaliny i dihydrohelenaliny oraz estrów tych substancji w kulturze in vitro A. montana, A. montana cv. Arbo, A. chamissonis oraz zastosowanie helenaliny i dihydrohelenaliny w przemyśle farmaceutycznym i w kosmetologii jako środków o właściwościach przeciwzapalnych, cytostatycznych, przeciwbólowych, przeciwobrzękowych, bakteriostatycznych i przeciwgrzybiczych.The subject of the application is a method for obtaining helenaline and dihydrohelenaline and esters of these substances in in vitro culture A. montana, A. montana cv. Arbo, A. chamissonis and the use of helenaline and dihydrohelenaline in the pharmaceutical industry and cosmetology as anti-inflammatory, cytostatic, analgesic, anti-edema, bacteriostatic and anti-fungal agents.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL413202A PL237808B1 (en) | 2015-07-20 | 2015-07-20 | Method for receiving helenalin and dihydrohelenalin and esters of these substances from in vitro cultures of Arnica and their application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL413202A PL237808B1 (en) | 2015-07-20 | 2015-07-20 | Method for receiving helenalin and dihydrohelenalin and esters of these substances from in vitro cultures of Arnica and their application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL413202A1 true PL413202A1 (en) | 2017-01-30 |
| PL237808B1 PL237808B1 (en) | 2021-05-31 |
Family
ID=57867759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL413202A PL237808B1 (en) | 2015-07-20 | 2015-07-20 | Method for receiving helenalin and dihydrohelenalin and esters of these substances from in vitro cultures of Arnica and their application |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL237808B1 (en) |
-
2015
- 2015-07-20 PL PL413202A patent/PL237808B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL237808B1 (en) | 2021-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120529T1 (en) | FUMARS PRODUCTS AND THEIR USE IN EDUCATION OF VARIOUS DISEASES | |
| AU2019268062A1 (en) | Benzoquinolone inhibitors of VMAT2 | |
| NI201600071A (en) | AUTOTAXIN INHIBITOR COMPOUNDS | |
| CR20160222U (en) | SOLID FORMS OF ACID {[- (3- CHLOROPHENYL) -3- HYDROXIPIRIDIN -2-CARBONIL] AMINO} ACETIC, COMPOSITIONS, AND USES OF THE SAME | |
| EA201790649A1 (en) | BENZE-SUBSTITUTED INDAZOLES AS BUB 1 INHIBITORS | |
| JO3512B1 (en) | Quinoxaline derivatives useful as fgfr kinase modulators | |
| CL2015002194A1 (en) | Erk inhibitors and their uses | |
| UY31277A1 (en) | NEW DERIVATIVES OF 6-TRIAZOLOPIRIDACINA -SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS | |
| UY33863A (en) | METHODS AND MEDICINES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| MX2015009058A (en) | Compositions and methods for treating chronic inflammation and inflammatory diseases. | |
| MX2016000794A (en) | High potency pancreatin pharmaceutical compositions. | |
| MX2018002318A (en) | Improved process for producing fucoxanthin and/or polysaccharides from microalgae. | |
| JO3310B1 (en) | Indolezine derivatives are new and a method for their production and the pharmaceutical formulations they contain | |
| CL2015001772A1 (en) | Pharmaceutical composition for the treatment of headache, and method of preparing it. | |
| CL2015002897A1 (en) | Bace1 inhibitors | |
| MX384877B (en) | LIPOIC ACID CHOLINE ESTER COMPOSITIONS AND METHODS OF USE. | |
| UY37534A (en) | METHOD FOR THE TREATMENT OF FIBROTIC DISEASES USING INTERFERON-LAMBDA | |
| MX385925B (en) | HIGH PURITY ORITAVANCIN AND METHOD FOR PRODUCING SAME. | |
| MX382116B (en) | COMPOSITIONS COMPRISING 15-HYDROXYEICOSAPENTAENOIC ACID (15-HEPE) AND METHODS FOR TREATING OR PREVENTING FIBROSIS USING THE SAME. | |
| CL2012003006A1 (en) | Compounds derived from unsaturated steroid lactones in position 7 (8) and their pharmaceutically acceptable salts and stereoisomers; pharmaceutical composition that includes them; and its use for the treatment of cancer. | |
| TR201905218T4 (en) | USEFUL VITANOLIDES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES. | |
| MX2020000135A (en) | New quinolinone compounds. | |
| CL2012003265A1 (en) | Tamarind seed polysaccharide for use in the treatment of infectious diseases; pharmaceutical and / or anti-inflammatory dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide. | |
| EA201400444A1 (en) | DERIVATIVES 2-OXOPYPERIDINYL | |
| IN2014MU00916A (en) |